Related Experiment Video
Updated: Aug 6, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Early Identification and Management of Biochemical Recurrence Following Radical Prostatectomy
Yuxin Duan1, Fawei He2, Zeng Li3
1Department of Urology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Annals of Surgical Oncology
|July 23, 2026
Summary
Biochemical recurrence (BCR) after prostatectomy is common. Multimodal artificial intelligence (AI) models integrating clinical, imaging, and pathology data show improved prediction of BCR compared to single approaches.
Area of Science:
- Urology
- Oncology
- Medical Imaging
- Artificial Intelligence
Background:
- Biochemical recurrence (BCR) is a frequent clinical event following radical prostatectomy (RP) for prostate cancer.
- Current management strategies face challenges in accurate risk stratification and personalized treatment.
- Existing guidelines address BCR definition, prognostic factors, imaging, and treatment options, but advancements are needed.
Purpose of the Study:
- To evaluate the efficacy of multimodal artificial intelligence (AI) models in predicting BCR after RP.
- To compare the performance of AI models integrating diverse data modalities against single-modal approaches.
Main Methods:
- Development and application of multimodal AI models incorporating clinical features, MRI-based radiomics, and whole-slide image pathology.
- Comparative analysis of predictive performance between multimodal and single-modal AI approaches for BCR post-RP.
Main Results:
- Multimodal AI models demonstrated superior performance in predicting BCR after RP.
- Integration of clinical, radiomic, and pathology data significantly enhanced predictive accuracy compared to individual data types.
Conclusions:
- Multimodal AI offers a promising advancement for accurate BCR risk stratification after RP.
- These AI models can potentially guide more timely and individualized treatment decisions for patients.
